Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shorouq Albelwi"'
Autor:
Khalid Al Sulaiman, Ghazwa B. Korayem, Khalid Eljaaly, Ali F. Altebainawi, Omar Al Harbi, Hisham A. Badreldin, Abdullah Al Harthi, Ghada Al Yousif, Ramesh Vishwakarma, Shorouq Albelwi, Rahaf Almutairi, Maha Almousa, Razan Alghamdi, Alaa Alhubaishi, Abdulrahman Alissa, Aisha Alharbi, Rahmah Algarni, Sarah Al Homaid, Khawla Al Qahtani, Nada Akhani, Abdulaleam Al Atassi, Ghassan Al Ghamdi, Ohoud Aljuhani
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Dexamethasone showed mortality benefits in patients with COVID-19. However, the optimal timing for dexamethasone initiation to prevent COVID-19 consequences such as respiratory failure requiring mechanical ventilation (MV) is debatable. As a
Externí odkaz:
https://doaj.org/article/93e752669c424ddb94f351d703a66c25
Autor:
Ohoud Aljuhani, Alaa Alhubaishi, Khalid Al Sulaiman, Abdullah Al Harthi, Ghassan Al Ghamdi, Omar Al Harbi, Aisha Alharbi, Khawla Kahtani, Ali F. Altebainawi, Khalid Eljaaly, Abdulaleam Al Atassi, Rahaf Almutairi, Ramesh Vishwakarma, Ghada Al Yousif, Rahmah Algarni, Sarah Al Homaid, Razan Alghamdi, Maha Almousa, Nada Akhani, Shorouq Albelwi, Ghazwa B. Korayem, Hisham A. Badreldin, Abdulrahman Alissa
Publikováno v:
Scientific Reports. 12
Background: Dexamethasone showed mortality benefits in COVID-19 patients. However, the optimal timing for dexamethasone initiation to prevent COVID-19 consequences such as respiratory failure requiring MV is debatable. As a result, the purpose of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf5f646e186517e9eab7ca59d4b6b6a6
https://doi.org/10.1038/s41598-022-13239-5
https://doi.org/10.1038/s41598-022-13239-5
Autor:
Khalid Al Sulaiman, Ghassan Al Ghamdi, Rahaf Almutairi, Ramesh Vishwakarma, Alaa Alhubaishi, Sarah Al Homaid, Razan Alghamdi, Ghada Al Yousif, Ohoud Al Juhani, Ghazwa B. Korayem, Omar Al Harbi, Ali F. Altebainawi, Rahmah Algarni, Shorouq Albelwi, Maha Almousa, Abdulrahman Alissa, Nada Akhani, Khawla Al Qahtani, Abdulaleam Al Atassi, Khalid Eljaaly, Abdullah Al Harthi, Hisham A. Badreldin, Aisha Alharbi
Rationale: It is unclear whether the timing of dexamethasone initiation is associated with positive outcomes. Objectives: To evaluate the appropriate timing of systemic dexamethasone initiation in critically ill patients with COVID-19. Methods: A mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c42663ad28de88df1e06691351a119
https://doi.org/10.21203/rs.3.rs-349677/v6
https://doi.org/10.21203/rs.3.rs-349677/v6
Autor:
Ramesh Vishwakarma, Abdulaleam Al Atassi, Alaa Alhubaishi, Khalid Eljaaly, Razan Alghamdi, Ghada Al Yousif, Rahmah Algarni, Hisham A. Badreldin, Aisha Alharbi, Rahaf Almutairi, Khalid Al Sulaiman, Ghassan Al Ghamdi, Omar Al Harbi, Maha Almousa, Nada Akhani, Ohoud Al Juhani, Shorouq Albelwi
Background: Corticosteroids, especially dexamethasone, showed a survival benefit in critically ill COVID 19 patients. However, it is unclear whether the timing of dexamethasone initiation is associated with positive outcomes. The aim of this study is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13726afad0c90e3d51b3298f7fd16363
https://doi.org/10.21203/rs.3.rs-349677/v3
https://doi.org/10.21203/rs.3.rs-349677/v3